Literature DB >> 29037457

Epidemiology and burden of HPV-related disease.

Beatriz Serrano1, María Brotons2, Francesc Xavier Bosch3, Laia Bruni4.   

Abstract

Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer in both men and women. High-risk HPV types are not only responsible for virtually all cervical cancer cases but also for a fraction of cancers of the vulva, vagina, penis, anus, and head and neck cancers. Furthermore, HPV is also the cause of anogenital warts and recurrent respiratory papillomatosis. Despite the availability of multiple preventative strategies, HPV-related cancer remains a leading cause of morbi-mortality in many parts of the world, particularly in less developed countries. Thus, in this review, we summarize the latest estimates of the global burden of HPV-related diseases, trends, the attributable fraction by HPV types, and the potential preventative fraction.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Attributable fraction; Cancer; Human papillomavirus; Papillomavirus vaccines; Prevention; Time trends

Mesh:

Substances:

Year:  2017        PMID: 29037457     DOI: 10.1016/j.bpobgyn.2017.08.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  98 in total

Review 1.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

2.  Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Authors:  Gabriele Galliverti; Stephan Wullschleger; Mélanie Tichet; Dhaarini Murugan; Nadine Zangger; Wesley Horton; Alan J Korman; Lisa M Coussens; Melody A Swartz; Douglas Hanahan
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

3.  Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).

Authors:  Jacqueline M Hirth; Yong-Fang Kuo; Jonathan M Starkey; Richard E Rupp; Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Vaccine       Date:  2019-06-07       Impact factor: 3.641

4.  No association between HPV vaccination and infertility in U.S. females 18-33 years old.

Authors:  Nicholas B Schmuhl; Katherine E Mooney; Xiao Zhang; Laura G Cooney; James H Conway; Noelle K LoConte
Journal:  Vaccine       Date:  2020-04-03       Impact factor: 3.641

5.  Association of HPV16 and 18 genomic copies with histological grades of cervical lesions.

Authors:  Negar Joharinia; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Jamal Sarvari
Journal:  Virusdisease       Date:  2019-07-22

6.  Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.

Authors:  Rodrigo Lopes da Silva; Zulmira da Silva Batista; Gerusinete Rodrigues Bastos; Ana Paula Almeida Cunha; Fábio Vidal Figueiredo; Lailson Oliveira de Castro; Liwerbeth Dos Anjos Pereira; Marcos Antonio Custódio Neto da Silva; Flávia Castello Branco Vidal; Maria Claudene Barros; Elmary da Costa Fraga; Luciane Maria Oliveira Brito; Maria do Carmo Lacerda Barbosa; Miguel Ângelo Martins Moreira; Maria do Desterro Soares Brandão Nascimento
Journal:  BMC Womens Health       Date:  2020-08-01       Impact factor: 2.809

Review 7.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

Review 8.  Vaginal microbiomes and ovarian cancer: a review.

Authors:  Jinyun Xu; Jing-Jie Peng; Wenqing Yang; Kun Fu; Yu Zhang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

9.  Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia.

Authors:  Jingbo Wu; Xiaojing Li; Xiuping Liu; Zuhua Gao
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

10.  Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.

Authors:  Ying-Ying Su; Bi-Zhen Lin; Hui Zhao; Juan Li; Zhi-Jie Lin; You-Lin Qiao; Li-Hui Wei; Yue-Mei Hu; Rong-Cheng Li; Si-Jie Zhuang; Guang Sun; Zi-Zheng Zheng; Shou-Jie Huang; Ting Wu; Jun Zhang; Hui-Rong Pan; Chang-Gui Li
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.